Biomarker Studies

Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases
Yun Wang, Wei Wei, Renren Ouyang, Rujia Chen, Ting Wang, Xu Yuan, Feng Wang, Hongyan Hou, Shiji Wu

Lupus Science & Medicine Jan 2024, 11 (1) e001125; DOI: 10.1136/lupus-2023-001125
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE
Daniel J Wallace, Roberta Vezza Alexander, Tyler O'Malley, Arezou Khosroshahi, Mehrnaz Hojjati, Konstantinos Loupasakis, Jeffrey Alper, Yvonne Sherrer, Maria Fondal, Rajesh Kataria, Tami Powell, Claudia Ibarra, Sonali Narain, Elena Massarotti, Arthur Weinstein, Thierry Dervieux

Lupus Science & Medicine Sep 2019, 6 (1) e000349; DOI: 10.1136/lupus-2019-000349
Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus
Shunsei Hirohata, Keiko Tanaka

Lupus Science & Medicine Nov 2019, 6 (1) e000359; DOI: 10.1136/lupus-2019-000359
Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE
Michelle A Petri, John Conklin, Tyler O'Malley, Thierry Dervieux

Lupus Science & Medicine Mar 2019, 6 (1) e000318; DOI: 10.1136/lupus-2019-000318
Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study
Thitima Benjachat Suttichet, Wonngarm Kittanamongkolchai, Chutipha Phromjeen, Sirirat Anutrakulchai, Thanachai Panaput, Atiporn Ingsathit, Nanticha Kamanamool, Vuddhidej Ophascharoensuk, Vasant Sumethakul, Yingyos Avihingsanon

Lupus Science & Medicine Apr 2019, 6 (1) e000298; DOI: 10.1136/lupus-2018-000298
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
Maureen McMahon, Brian Skaggs, Jennifer Grossman, Weng Kee Wong, Lori Sahakian, Weiling Chen, Bevra Hahn

Lupus Science & Medicine Jun 2019, 6 (1) e000321; DOI: 10.1136/lupus-2019-000321
Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus
Guillermo Ruacho, Ronaldo Lira-Junior, Iva Gunnarsson, Elisabet Svenungsson, Elisabeth A Boström

Lupus Science & Medicine Mar 2022, 9 (1) e000607; DOI: 10.1136/lupus-2021-000607
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
Serena Fasano, Michele Iudici, Melania Alessia Coscia, Valentina Messiniti, Alessia Borgia, Rosella Tirri, Francesco Ciccia

Lupus Science & Medicine Mar 2022, 9 (1) e000681; DOI: 10.1136/lupus-2022-000681
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial
Stephen McDonald, Sean Yiu, Li Su, Caroline Gordon, Matt Truman, Laura Lisk, Neil Solomons, Ian N Bruce

Lupus Science & Medicine May 2022, 9 (1) e000584; DOI: 10.1136/lupus-2021-000584
Phenotypical changes and clinical significance of CD4⁺/CD8⁺ T cells in SLE
Shiwen Yuan, Yanting Zeng, Jiawei Li, Cuicui Wang, Weinian Li, Zhixiang He, Jinghua Ye, Fangfei Li, Yi Chen, Xiaojun Lin, Na Yu, Xiaoyan Cai

Lupus Science & Medicine Jun 2022, 9 (1) e000660; DOI: 10.1136/lupus-2022-000660

Main menu

Biomarker Studies

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Biomarker Studies

Pages